Biocon Denies API Selloff Rumors As It Completes Biologics Integration

Indian Giant Dismisses Media Reports Of $1.5bn Divestment As ‘Baseless And Speculative’

 
• By Dave Wallace
  
API icon
Biocon has denied reports that it is evaluating options for its API business • Source: Shutterstock

More from Strategy

More from Business